BRIEF published on 04/14/2026 at 17:50, 4 months 27 days ago IMPLANET Reports 18% Revenue Growth in Q1 2026 Revenue Growth Financial Strategy United States Medical Equipment IMPLANET
BRIEF published on 04/14/2026 at 17:50, 4 months 27 days ago IMPLANET annonce une croissance de son chiffre d'affaires de 18 % au premier trimestre 2026 Stratégie Financière États-Unis Croissance Des Revenus Équipement Médical IMPLANETTE
PRESS RELEASE published on 04/14/2026 at 17:45, 4 months 27 days ago Inside Information / Other news releases IMPLANET reports Q1 2026 revenue of €3.03 million, up 18%, driven by strong growth in the United States and medical equipment distribution, particularly the ultrasonic scalpel (SMTP) Revenue United States Medical Equipment IMPLANET Q1 2026
BRIEF published on 04/14/2025 at 18:46, 1 year 4 months ago Compte rendu de l’Assemblée Générale Mixte d'IMPLANET Chiffre D’affaires Assemblée Générale Mandats Renouvelés Résolutions Adoptées IMPLANET
BRIEF published on 04/14/2025 at 18:46, 1 year 4 months ago Minutes of the IMPLANET Combined General Meeting Turnover General Assembly Mandates Renewed Resolutions Adopted IMPLANET
PRESS RELEASE published on 04/14/2025 at 18:41, 1 year 4 months ago Informations privilégiées / Autres communiqués Implanet tient son Assemblée Générale Mixte avec succès. Résolutions adoptées incluant ratification de cooptation et renouvellement de mandats. Prochain communiqué financier le 8 juillet 2025 Resolutions Assemblée Générale Mixte Communiqué Financier Cooptation IMPLANET
BRIEF published on 10/08/2024 at 18:51, 1 year 11 months ago IMPLANET : Croissance de 50% du chiffre d'affaires au troisième trimestre 2024 Chiffre D'affaires Croissance Marché Américain Technologies Médicales Équipements Médicaux
BRIEF published on 10/08/2024 at 18:51, 1 year 11 months ago IMPLANET: 50% growth in turnover in the third quarter of 2024 Growth American Market Turnover Medical Equipment Medical Technologies
PRESS RELEASE published on 10/08/2024 at 18:46, 1 year 11 months ago Informations privilégiées / Autres communiqués Implanet annonce un chiffre d'affaires en forte croissance au troisième trimestre 2024, soutenu par des activités en France et aux USA, avec un focus sur la chirurgie orthopédique Chiffre D'affaires Croissance France USA IMPLANET
PRESS RELEASE published on 10/08/2024 at 18:46, 1 year 11 months ago Inside Information / Other news releases IMPLANET announces €2.3 million Q3 revenue with 50% growth and €6.4 million for 9 months 2024. Exclusive partnership success with elliquence. Company aims for strategic growth in spine surgery market Revenue Growth Exclusive Partnership Spine Surgery IMPLANET
Published on 09/12/2026 at 02:35, 11 hours 6 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 41 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 36 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 16 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 41 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 11 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 26 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 31 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 56 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 26 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
